0001123292-26-000220.txt : 20260220 0001123292-26-000220.hdr.sgml : 20260220 20260220115206 ACCESSION NUMBER: 0001123292-26-000220 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20260220 DATE AS OF CHANGE: 20260220 EFFECTIVENESS DATE: 20260220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gilgamesh Pharma PML SPV 1 LP CENTRAL INDEX KEY: 0002112386 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-574160 FILM NUMBER: 26657616 BUSINESS ADDRESS: STREET 1: 2121 BISCAYNE BLVD #1761 CITY: MIAMI STATE: FL ZIP: 33137 BUSINESS PHONE: 000-000-0000 MAIL ADDRESS: STREET 1: 2121 BISCAYNE BLVD #1761 CITY: MIAMI STATE: FL ZIP: 33137 D 1 primary_doc.xml X0708 D LIVE 0002112386 Gilgamesh Pharma PML SPV 1 LP 2121 Biscayne Blvd #1761 Miami FL FLORIDA 33137 732-995-4059 DELAWARE None None Limited Partnership true 2026 N/A Prime Movers Lab GP IV LLC 2121 Biscayne Blvd #1761 Miami FL FLORIDA 33137 Executive Officer General Partner of the Issuer Dakin Sloss 2121 Biscayne Blvd #1761 Miami FL FLORIDA 33137 Director Manager of the Investment Adviser of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 3C.1 06b 3C false true false true true false 0 Indefinite 0 Indefinite false 0 0 0 0 The Issuer's General Partner (or an Affiliate thereof) is entitled to carried interest. The carried interest is set forth in the Issuer's governing agreement. false Gilgamesh Pharma PML SPV 1 LP /s/ Taylor Frankel Taylor Frankel Chief Financial Officer 2026-02-20